Abattis Bioceuticals Corp. (ATTBF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 9.41 Million | -8.27 Million | -1.22 Million | -733.21 Thousand | -1.82 Million | -2.1 Million |
| Net Income | -3.06 Million | -77.65 Million | -7.92 Million | -2.41 Million | -5.57 Million | -7.61 Million |
| Depreciation & Amortization | 109.01 Thousand | 37.36 Thousand | 120.89 Thousand | 130.03 Thousand | 183.09 Thousand | 104.71 Thousand |
| Deferred income taxes | -706.93 Thousand | 17.19 Million | 953.94 Thousand | -287.42 Thousand | -419.29 Thousand | -39.86 Thousand |
| Stock-based compensation | 1619.00 | 494.8 Thousand | 718.64 Thousand | 67.92 Thousand | 241.23 Thousand | 4.7 Million |
| Change in working capital | 8.44 Million | -712.13 Thousand | 187.87 Thousand | 308.59 Thousand | 536.1 Thousand | 223.13 Thousand |
| Other non-cash items | 4.62 Million | 52.35 Million | 5.67 Million | 1.17 Million | 3.2 Million | 513.46 Thousand |
| Investing Cash Flow | -11.51 Million | -16.23 Million | -430.93 Thousand | 44.2 Thousand | 1.11 Million | -2.03 Million |
| Investments in PPE | -5.06 Million | -233.74 Thousand | -430.93 Thousand | -45.7 Thousand | -145.95 Thousand | -464.58 Thousand |
| Acquisitions | -9.85 Million | -16 Million | - | - | - | -26.77 Thousand |
| Investment purchases | 5 Million | - | - | - | - | -348.06 Thousand |
| Sales/Maturities of investments | 3.39 Million | - | - | 83.07 Thousand | 99.87 Thousand | -117.76 Thousand |
| Other Investing Activities | -5 Million | -1.00 | -1493.00 | 6655.00 | 1.16 Million | -1.31 Million |
| Financing Cash Flow | 60 Thousand | 28.05 Million | 2.14 Million | 566.43 Thousand | 724.91 Thousand | 4.27 Million |
| Debt repayment | - | - | - | - | - | -290.15 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 27.57 Million | 2.14 Million | 536 Thousand | 604.91 Thousand | 4.56 Million |
| Other Financing Activities | 60 Thousand | 475 Thousand | - | 30.43 Thousand | 120 Thousand | - |
| Accounts receivables | 392.94 Thousand | - | -89.52 Thousand | - | - | - |
| Accounts payables | 1.36 Million | -136.21 Thousand | 289.41 Thousand | - | - | - |
| Inventory | -237.36 Thousand | -30.45 Thousand | 289.41 Thousand | - | - | - |
| Other working capital | 7.31 Million | -681.67 Thousand | -12 Thousand | - | - | - |
| Cash at beginning of period | 4.06 Million | 525.56 Thousand | 38.48 Thousand | 157.75 Thousand | 135.17 Thousand | 5327.00 |
| Cash at end of period | 2.01 Million | 4.06 Million | 525.56 Thousand | 38.48 Thousand | 157.75 Thousand | 135.17 Thousand |
| Capital Expenditure | -5.06 Million | -233.74 Thousand | -430.93 Thousand | -45.7 Thousand | -145.95 Thousand | -464.58 Thousand |
| Effect of forex changes on cash | 1.00 | - | - | 3300.00 | 2052.00 | - |
| Net cash flow / Change in cash | -2.04 Million | 3.53 Million | 487.08 Thousand | -119.27 Thousand | 22.58 Thousand | 129.84 Thousand |
| Free Cash Flow | 4.35 Million | -8.51 Million | -1.65 Million | -778.91 Thousand | -1.96 Million | -2.57 Million |
| Breakdown | 2019 Q4 | 2019 FY | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -926.05 Thousand | -3.06 Million | -735.65 Thousand | -142.54 Thousand | -1.25 Million | -77.65 Million |
| Depreciation & Amortization | 46.4 Thousand | 109.01 Thousand | 21.24 Thousand | 21.08 Thousand | 20.27 Thousand | 37.36 Thousand |
| Deferred income taxes | - | -706.93 Thousand | - | - | - | 17.19 Million |
| Stock-based compensation | - | 1619.00 | - | - | 1619.00 | 494.8 Thousand |
| Change in working capital | -147.06 Thousand | 8.44 Million | 8.21 Million | 408.79 Thousand | -28.71 Thousand | -712.13 Thousand |
| Other non-cash items | 4.96 Million | 4.62 Million | -2379.00 | -877.38 Thousand | -167.6 Thousand | 52.35 Million |
| Investing Cash Flow | -4.6 Million | -11.51 Million | -8.47 Million | 1.61 Million | -55.22 Thousand | -16.23 Million |
| Investments in PPE | -5.03 Million | -5.06 Million | -1544.00 | -17.43 Thousand | -5227.00 | -233.74 Thousand |
| Acquisitions | -9.85 Million | -9.85 Million | - | - | - | -16 Million |
| Investment purchases | - | 5 Million | -8.32 Million | -1.48 Million | -50 Thousand | - |
| Sales/Maturities of investments | 431.08 Thousand | 3.39 Million | -151.18 Thousand | - | - | - |
| Other Investing Activities | 4.85 Million | -5 Million | - | 3.11 Million | - | -1.00 |
| Financing Cash Flow | - | 60 Thousand | - | - | 60 Thousand | 28.05 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | -60 Thousand | 60 Thousand | 27.57 Million |
| Other Financing Activities | - | 60 Thousand | - | - | 60 Thousand | 475 Thousand |
| Accounts receivables | - | 392.94 Thousand | - | - | - | - |
| Accounts payables | -154.78 Thousand | 1.36 Million | - | - | - | -136.21 Thousand |
| Inventory | 13.63 Thousand | -237.36 Thousand | -251 Thousand | - | - | -30.45 Thousand |
| Other working capital | -5921.00 | 7.31 Million | 8.46 Million | - | - | -681.67 Thousand |
| Cash at beginning of period | 2.68 Million | 4.06 Million | 3.66 Million | 2.63 Million | 4.06 Million | 525.56 Thousand |
| Cash at end of period | 2.01 Million | 2.01 Million | 2.68 Million | 3.66 Million | 2.63 Million | 4.06 Million |
| Capital Expenditure | -5.03 Million | -5.06 Million | -1544.00 | -17.43 Thousand | -5227.00 | -233.74 Thousand |
| Effect of forex changes on cash | - | 1.00 | - | - | - | - |
| Net cash flow / Change in cash | -670.57 Thousand | -2.04 Million | -975.41 Thousand | 1.02 Million | -1.42 Million | 3.53 Million |
| Free Cash Flow | -1.1 Million | 4.35 Million | 7.49 Million | -607.47 Thousand | -1.43 Million | -8.51 Million |
ENTI
1606
2B4
MSDL
7678
PHYOF